117 related articles for article (PubMed ID: 2148055)
1. Plasmin-induced platelet aggregation is accompanied by cleavage of aggregin and indirectly mediated by calpain.
Puri RN; Zhou FX; Colman RF; Colman RW
Am J Physiol; 1990 Dec; 259(6 Pt 1):C862-8. PubMed ID: 2148055
[TBL] [Abstract][Full Text] [Related]
2. Thrombin-induced platelet aggregation involves an indirect proteolytic cleavage of aggregin by calpain.
Puri RN; Zhou FX; Bradford H; Hu CJ; Colman RF; Colman RW
Arch Biochem Biophys; 1989 Jun; 271(2):346-58. PubMed ID: 2543293
[TBL] [Abstract][Full Text] [Related]
3. Aggregation of washed platelets by plasminogen and plasminogen activators is mediated by plasmin and is inhibited by a synthetic peptide disulfide.
Puri RN; Hu CJ; Matsueda R; Umeyama H; Colman RW
Thromb Res; 1992 Mar; 65(4-5):533-47. PubMed ID: 1535463
[TBL] [Abstract][Full Text] [Related]
4. Modulation of thrombin-induced platelet aggregation by inhibition of calpain by a synthetic peptide derived from the thiol-protease inhibitory sequence of kininogens and S-(3-nitro-2-pyridinesulfenyl)-cysteine.
Puri RN; Matsueda R; Umeyama H; Bradford HN; Colman RW
Eur J Biochem; 1993 May; 214(1):233-41. PubMed ID: 8389701
[TBL] [Abstract][Full Text] [Related]
5. Selective inhibition of thrombin- and plasmin-induced platelet aggregation by a synthetic peptide disulfide.
Puri RN; Hu CJ; Bradford HN; Matsueda R; Umeyama H; Colman RW
Trans Assoc Am Physicians; 1989; 102():13-9. PubMed ID: 2561638
[TBL] [Abstract][Full Text] [Related]
6. Platelet activation by 2-(4-bromo-2,3-dioxobutylthio)adenosine 5'-diphosphate is mediated by its binding to a putative ADP receptor, aggregin.
Puri RN; Colman RF; Colman RW
Eur J Biochem; 1996 Mar; 236(3):862-70. PubMed ID: 8665907
[TBL] [Abstract][Full Text] [Related]
7. Cleavage of a 100 kDa membrane protein (aggregin) during thrombin-induced platelet aggregation is mediated by the high affinity thrombin receptors.
Puri RN; Zhou FX; Colman RF; Colman RW
Biochem Biophys Res Commun; 1989 Aug; 162(3):1017-24. PubMed ID: 2475104
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of thrombin-induced platelet aggregation by high molecular weight kininogen.
Puri RN; Gustafson EJ; Zhou FX; Bradford H; Colman RF; Colman RW
Trans Assoc Am Physicians; 1987; 100():232-40. PubMed ID: 3455067
[TBL] [Abstract][Full Text] [Related]
9. Aggregin: a platelet ADP receptor that mediates activation.
Colman RW
FASEB J; 1990 Mar; 4(5):1425-35. PubMed ID: 2407587
[TBL] [Abstract][Full Text] [Related]
10. Design and synthesis of a kininogen-based selective inhibitor of thrombin-induced platelet aggregation.
Matsueda R; Umeyama H; Puri RN; Bradford HN; Colman RW
Pept Res; 1994; 7(1):32-5. PubMed ID: 8019060
[TBL] [Abstract][Full Text] [Related]
11. Specificity of the sequence in Phe-Gln-Val-Val-Cys (-3-nitro-2-pyridinesulfenyl)-Gly-NH2--a selective inhibitor of thrombin-induced platelet aggregation.
Puri RN; Matsueda R; Umeyama H; Colman RW
Thromb Res; 1993 Nov; 72(3):183-91. PubMed ID: 8303657
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of ADP-induced platelet responses by covalent modification of aggregin, a putative ADP receptor, by 8-(4-bromo-2,3-dioxobutylthio)ADP.
Puri RN; Kumar A; Chen H; Colman RF; Colman RW
J Biol Chem; 1995 Oct; 270(41):24482-8. PubMed ID: 7592664
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of ADP-induced platelet activation by 7-chloro-4-nitrobenz-2-oxa-1,3-diazole: covalent modification of aggregin, a putative ADP receptor.
Puri RN; Colman RW
J Cell Biochem; 1996 Apr; 61(1):97-108. PubMed ID: 8726359
[TBL] [Abstract][Full Text] [Related]
14. Reocclusion after thrombolytic therapy: strategies for inhibiting thrombin-induced platelet aggregation.
Puri RN; Colman RW
Blood Coagul Fibrinolysis; 1993 Jun; 4(3):465-78. PubMed ID: 8329574
[TBL] [Abstract][Full Text] [Related]
15. High molecular weight kininogen inhibits thrombin-induced platelet aggregation and cleavage of aggregin by inhibiting binding of thrombin to platelets.
Puri RN; Zhou F; Hu CJ; Colman RF; Colman RW
Blood; 1991 Feb; 77(3):500-7. PubMed ID: 1846761
[TBL] [Abstract][Full Text] [Related]
16. Platelet receptors.
Colman RW
Hematol Oncol Clin North Am; 1990 Feb; 4(1):27-42. PubMed ID: 2155904
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of ADP-induced platelet shape change and aggregation by o-phthalaldehyde: evidence for covalent modification of cysteine and lysine residues.
Puri RN; Colman RW
Arch Biochem Biophys; 1991 May; 286(2):419-27. PubMed ID: 1910292
[TBL] [Abstract][Full Text] [Related]
18. Immunoaffinity method to identify aggregin, a putative ADP-receptor in human blood platelets.
Puri RN; Colman RW
Arch Biochem Biophys; 1997 Nov; 347(2):263-70. PubMed ID: 9367534
[TBL] [Abstract][Full Text] [Related]
19. A novel method for chemical modification of functional groups other than a carboxyl group in proteins by N-ethyl-5-phenylisooxazolium-3'-sulfonate (Woodward's reagent-K): inhibition of ADP-induced platelet responses involves covalent modification of aggregin, an ADP receptor.
Puri RN; Colman RW
Anal Biochem; 1996 Sep; 240(2):251-61. PubMed ID: 8811919
[TBL] [Abstract][Full Text] [Related]
20. Distinction between glycoprotein IIIa and the 100-kDa membrane protein (aggregin) mediating ADP-induced platelet activation.
Colman RW; Figures WR; Wu QX; Chung SY; Morinelli TA; Tuszynski GP; Colman RF; Niewiarowski S
Arch Biochem Biophys; 1988 Apr; 262(1):298-306. PubMed ID: 3281588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
